NCT01665157 is a NA clinical trial of Enimaclin® in Dietary Modification, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT01665157?

NCT01665157 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT01665157?

Interventions in NCT01665157: Enimaclin®, Self-controlled diet, 2L PEG-ELS, low volume 1.5L PEG-ELS.

What condition does NCT01665157 study?

NCT01665157 studies Dietary Modification.

Is NCT01665157 still recruiting?

NCT01665157 is currently completed. Last updated 18 February 2014.

Are results published for NCT01665157?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2014-02-18 · How we verify

NCT01665157

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized, Single-blinded, Comparative Study to Evaluate the Efficacy and the Acceptability of Low-residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

Completed NA Results posted Last updated 18 February 2014

What this trial tests

NA trial testing Enimaclin® in Dietary Modification in 180 participants. Completed in 1 June 2012.

Timeline

1 November 2011

Primary endpoint
1 June 2012

1 June 2012

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Enrollment	180
Start date	1 November 2011
Primary completion	1 June 2012
Estimated completion	1 June 2012
Sites	4 locations across Taiwan

Drugs / interventions tested

Enimaclin®
Self-controlled diet
2L PEG-ELS — full drug profile →
low volume 1.5L PEG-ELS — full drug profile →

Conditions studied

Dietary Modification — all drugs for Dietary Modification →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 75, any sex, with Dietary Modification. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Overall Cleansing Level at Colonoscopy by Ottawa Bowel Preparation Scale
Time frame: 1 day
Ottawa preparation scale: Colon is defined into 3 segments: Right(cecum, ascending), mid(transverse, descending), rectosigmoid. Each is scored from 0 to 4, 0 is best and 4 is worst. Fluid quantity of whole is scored as 0, small; 1, moderate; 2 large amount. The scale will be summation of the clearness of 3 segments of colon and overall fluid quantity. It ranged from 0 to 14, 0 is the most clean co
Overall Cleansing Level at Colonoscopy by Aronchick Scale
Time frame: 1 day
The overall proportion of participants scored as Excellent or Good by Aronchick scale. Description of Aronchick scale:It categorized colon cleansing into 5 level: Excellent, good, fair, poor, inadequate. It is categorical and cannot be summed. We will present
Total Volume of Purgatives That Ingested
Time frame: 1 day
The total volume of PEG-ELS (Liter) that ingested or could be ingested by examinee before colonoscopy
Segmental Cleansing Level at Colonoscopy (Right Segment Preparation Failure)
Time frame: 1 day
Segmental score of Ottawa bowel preparation scale was analyzed. The proportion of "right segment" preparation failure, defined as segmental score as "3 poor" or "4 inadequate", was presented.

Sponsor's own description

The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dietary Modification

Currently open trials in the same condition.

NCT06888687 — Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes. · NA · recruiting
NCT06590805 — Electroacupoint for Diminutive Milk Production · NA · recruiting
NCT03681054 — Dietary Management of Gestational Diabetes · NA · active not recruiting
NCT03667404 — Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study · Phase 2 · active not recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01665157 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 18 February 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01665157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing